MA46038B1 - Composés de sulfonimidoylpurinone substitués dans la position 7 pour le traitement et la prophylaxie d'infection virale - Google Patents
Composés de sulfonimidoylpurinone substitués dans la position 7 pour le traitement et la prophylaxie d'infection viraleInfo
- Publication number
- MA46038B1 MA46038B1 MA46038A MA46038A MA46038B1 MA 46038 B1 MA46038 B1 MA 46038B1 MA 46038 A MA46038 A MA 46038A MA 46038 A MA46038 A MA 46038A MA 46038 B1 MA46038 B1 MA 46038B1
- Authority
- MA
- Morocco
- Prior art keywords
- prophylaxis
- treatment
- viral infection
- compounds substituted
- sulfonimidoylpurinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La présente invention concerne des composés de formule (i), dans laquelle r1, r2 et r3 sont tels que décrits ici, et leurs promédicaments ou leur sel, énantiomère ou diastéréoisomère pharmaceutiquement acceptables de ceux-ci, des compositions comprenant les composés et des procédés d'utilisation des composés comme agonistes de tlr7 pour le traitement et la prophylaxie d'infections virales.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2016097140 | 2016-08-29 | ||
CN2017092653 | 2017-07-12 | ||
PCT/EP2017/071514 WO2018041763A1 (fr) | 2016-08-29 | 2017-08-28 | Composés de sulfonimidoylpurinone substitués dans la position 7 pour le traitement et la prophylaxie d'infection virale |
Publications (2)
Publication Number | Publication Date |
---|---|
MA46038A MA46038A (fr) | 2019-07-03 |
MA46038B1 true MA46038B1 (fr) | 2021-05-31 |
Family
ID=59738346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA46038A MA46038B1 (fr) | 2016-08-29 | 2017-08-28 | Composés de sulfonimidoylpurinone substitués dans la position 7 pour le traitement et la prophylaxie d'infection virale |
Country Status (31)
Country | Link |
---|---|
US (3) | US10233184B2 (fr) |
EP (2) | EP3865482A1 (fr) |
JP (2) | JP7013467B2 (fr) |
KR (2) | KR102459155B1 (fr) |
CN (1) | CN109641904B (fr) |
AU (3) | AU2017320742B2 (fr) |
BR (1) | BR112019003519A2 (fr) |
CA (1) | CA3034148A1 (fr) |
CL (1) | CL2019000512A1 (fr) |
CO (1) | CO2019000932A2 (fr) |
CR (1) | CR20190087A (fr) |
DK (1) | DK3504210T3 (fr) |
ES (1) | ES2867849T3 (fr) |
HR (1) | HRP20210621T1 (fr) |
HU (1) | HUE053944T2 (fr) |
IL (3) | IL293475A (fr) |
MA (1) | MA46038B1 (fr) |
MX (2) | MX2019002129A (fr) |
MY (1) | MY197408A (fr) |
NZ (1) | NZ750604A (fr) |
PE (1) | PE20190476A1 (fr) |
PH (1) | PH12019500432A1 (fr) |
PL (1) | PL3504210T3 (fr) |
PT (1) | PT3504210T (fr) |
RS (1) | RS61752B1 (fr) |
RU (1) | RU2751349C2 (fr) |
SG (2) | SG10202010520SA (fr) |
SI (1) | SI3504210T1 (fr) |
TW (1) | TWI671300B (fr) |
UA (1) | UA124270C2 (fr) |
WO (1) | WO2018041763A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112017023959B1 (pt) * | 2015-05-08 | 2023-05-02 | F. Hoffmann-La Roche Ag | Novos compostos de sulfonimidoilpurinona e derivados para o tratamento e profilaxia de infecção por vírus |
IL293475A (en) * | 2016-08-29 | 2022-08-01 | Hoffmann La Roche | 7-substituted sulfonimidylpurinone compounds for the treatment and prevention of viral infection |
BR112019004560A2 (pt) * | 2016-09-13 | 2019-07-02 | Hoffmann La Roche | tratamento combinado com agonista de tlr7 e um inibidor de formação de capsídeo de hbv |
EP3752505B1 (fr) | 2018-02-12 | 2023-01-11 | F. Hoffmann-La Roche AG | Nouveaux composés et dérivés de sulfone pour le traitement et la prophylaxie d'une infection virale |
CA3091950A1 (fr) * | 2018-02-28 | 2019-09-06 | F. Hoffmann-La Roche Ag | Nouveaux composes sulfonimidoylpurinone substitues en position 7 et derives pour le traitement et la prophylaxie du cancer du foie |
BR112021004590A2 (pt) | 2018-09-12 | 2021-05-25 | Silverback Therapeutics, Inc. | composições para o tratamento de doença com conjugados imunoestimuladores |
MX2021009496A (es) | 2019-02-08 | 2021-09-08 | Progeneer Inc | Complejo de colesterol-agonista del receptor 7 u 8 tipo larga distancia, y uso del mismo. |
AU2020358726A1 (en) | 2019-10-01 | 2022-04-07 | Silverback Therapeutics, Inc. | Combination therapy with immune stimulatory conjugates |
JP2023514727A (ja) | 2020-02-21 | 2023-04-07 | シルバーバック セラピューティックス インコーポレイテッド | ネクチン-4抗体コンジュゲートおよびその使用 |
AU2021231160A1 (en) | 2020-03-02 | 2022-09-22 | Progeneer Inc. | Live-pathogen-mimetic nanoparticles based on pathogen cell wall skeleton, and production method thereof |
CN116209678A (zh) | 2020-07-01 | 2023-06-02 | 安尔士制药公司 | 抗asgr1抗体缀合物及其用途 |
CN116056725A (zh) | 2020-08-04 | 2023-05-02 | 蛋白科技先鋒 | 活性位点暂时灭活的功能性药物与Toll样受体7或8激动剂的缀合物及其用途 |
US20230355750A1 (en) | 2020-08-04 | 2023-11-09 | Progeneer Inc. | Kinetically acting adjuvant ensemble |
WO2022031021A1 (fr) | 2020-08-04 | 2022-02-10 | 성균관대학교산학협력단 | Vaccin à arnm comprenant un adjuvant permettant un contrôle cinétique |
CN114787165B (zh) * | 2020-09-27 | 2023-02-28 | 上海维申医药有限公司 | 大环tlr7激动剂、其制备方法、药物组合物及其用途 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0141927B1 (fr) * | 1983-08-18 | 1991-10-30 | Beecham Group Plc | Dérivés de guanine antiviraux |
TW552261B (en) | 1996-07-03 | 2003-09-11 | Japan Energy Corp | Novel purine derivative |
AUPO912997A0 (en) * | 1997-09-11 | 1997-10-02 | Commonwealth Scientific And Industrial Research Organisation | Antiviral agents |
JP4375901B2 (ja) * | 1997-11-28 | 2009-12-02 | 大日本住友製薬株式会社 | 新規な複素環化合物 |
JPH11180981A (ja) * | 1997-12-19 | 1999-07-06 | Sumitomo Pharmaceut Co Ltd | 複素環誘導体 |
TW572758B (en) | 1997-12-22 | 2004-01-21 | Sumitomo Pharma | Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives |
JP4189048B2 (ja) | 1997-12-26 | 2008-12-03 | 大日本住友製薬株式会社 | 複素環化合物 |
ATE443507T1 (de) * | 2002-03-15 | 2009-10-15 | Univ Wayne State | Neue 2-amino-9-((2- hydroxymethyl)cyclopropylidenmethyl)-purine als antivirale mittel |
TWI349671B (en) * | 2002-09-27 | 2011-10-01 | Dainippon Sumitomo Pharma Co | Novel adenine derivative and its use |
BRPI0611435A2 (pt) | 2005-05-04 | 2010-09-08 | Pfizer Ltd | derivados de 2-amido-6-amino-8-oxopurina, composições farmacêuticas, uso e processo de preparo dos mesmos |
DE102006053049A1 (de) | 2006-11-10 | 2008-05-15 | Daimler Ag | Staufach mit einer Abdeckeinrichtung |
EA021463B1 (ru) | 2007-06-29 | 2015-06-30 | Джилид Сайэнс, Инк. | Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7 |
CN101239980B (zh) | 2008-02-18 | 2011-06-22 | 靳广毅 | 免疫受体调节剂偶联体前体和偶联体及其应用 |
PL2364314T3 (pl) * | 2008-12-09 | 2014-08-29 | Gilead Sciences Inc | Modulatory receptorów Toll-podobnych |
KR101793300B1 (ko) * | 2009-10-22 | 2017-11-02 | 길리애드 사이언시즈, 인코포레이티드 | 특히 바이러스성 감염의 치료에 유용한 퓨린 또는 데아자퓨린의 유도체 |
WO2011079016A1 (fr) | 2009-12-22 | 2011-06-30 | Gilead Sciences, Inc. | Méthodes de traitement d'une infection par le vhb et le vhc |
US8501724B1 (en) * | 2012-01-31 | 2013-08-06 | Pharmacyclics, Inc. | Purinone compounds as kinase inhibitors |
AU2015303558B2 (en) | 2014-08-15 | 2018-07-12 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Pyrrolopyrimidine compounds used as TLR7 agonist |
BR112017023959B1 (pt) * | 2015-05-08 | 2023-05-02 | F. Hoffmann-La Roche Ag | Novos compostos de sulfonimidoilpurinona e derivados para o tratamento e profilaxia de infecção por vírus |
IL293475A (en) * | 2016-08-29 | 2022-08-01 | Hoffmann La Roche | 7-substituted sulfonimidylpurinone compounds for the treatment and prevention of viral infection |
-
2017
- 2017-08-28 IL IL293475A patent/IL293475A/en unknown
- 2017-08-28 EP EP20207475.3A patent/EP3865482A1/fr not_active Withdrawn
- 2017-08-28 CA CA3034148A patent/CA3034148A1/fr active Pending
- 2017-08-28 SG SG10202010520SA patent/SG10202010520SA/en unknown
- 2017-08-28 AU AU2017320742A patent/AU2017320742B2/en active Active
- 2017-08-28 RS RS20210489A patent/RS61752B1/sr unknown
- 2017-08-28 RU RU2019107957A patent/RU2751349C2/ru active
- 2017-08-28 ES ES17758527T patent/ES2867849T3/es active Active
- 2017-08-28 SI SI201730728T patent/SI3504210T1/sl unknown
- 2017-08-28 MA MA46038A patent/MA46038B1/fr unknown
- 2017-08-28 TW TW106129087A patent/TWI671300B/zh active
- 2017-08-28 HU HUE17758527A patent/HUE053944T2/hu unknown
- 2017-08-28 EP EP17758527.0A patent/EP3504210B1/fr active Active
- 2017-08-28 PL PL17758527T patent/PL3504210T3/pl unknown
- 2017-08-28 PE PE2019000346A patent/PE20190476A1/es unknown
- 2017-08-28 NZ NZ750604A patent/NZ750604A/en unknown
- 2017-08-28 MX MX2019002129A patent/MX2019002129A/es unknown
- 2017-08-28 WO PCT/EP2017/071514 patent/WO2018041763A1/fr active Application Filing
- 2017-08-28 BR BR112019003519-2A patent/BR112019003519A2/pt unknown
- 2017-08-28 SG SG11201901633WA patent/SG11201901633WA/en unknown
- 2017-08-28 PT PT177585270T patent/PT3504210T/pt unknown
- 2017-08-28 DK DK17758527.0T patent/DK3504210T3/da active
- 2017-08-28 UA UAA201903059A patent/UA124270C2/uk unknown
- 2017-08-28 CN CN201780052692.6A patent/CN109641904B/zh active Active
- 2017-08-28 KR KR1020197008982A patent/KR102459155B1/ko active Application Filing
- 2017-08-28 KR KR1020227036198A patent/KR20220147702A/ko not_active Application Discontinuation
- 2017-08-28 IL IL284255A patent/IL284255B/en unknown
- 2017-08-28 CR CR20190087A patent/CR20190087A/es unknown
- 2017-08-28 JP JP2019532184A patent/JP7013467B2/ja active Active
- 2017-08-28 MY MYPI2019001082A patent/MY197408A/en unknown
- 2017-08-29 US US15/689,136 patent/US10233184B2/en active Active
-
2019
- 2019-01-29 US US16/260,744 patent/US10752630B2/en active Active
- 2019-01-30 CO CONC2019/0000932A patent/CO2019000932A2/es unknown
- 2019-02-07 IL IL264710A patent/IL264710B/en unknown
- 2019-02-21 MX MX2021006902A patent/MX2021006902A/es unknown
- 2019-02-26 CL CL2019000512A patent/CL2019000512A1/es unknown
- 2019-02-27 PH PH12019500432A patent/PH12019500432A1/en unknown
-
2020
- 2020-08-24 US US17/001,572 patent/US20200385387A1/en not_active Abandoned
-
2021
- 2021-04-19 HR HRP20210621TT patent/HRP20210621T1/hr unknown
- 2021-06-24 AU AU2021204303A patent/AU2021204303B2/en active Active
-
2022
- 2022-01-17 JP JP2022004832A patent/JP7214900B2/ja active Active
- 2022-06-30 AU AU2022204697A patent/AU2022204697A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA46038A (fr) | Composés de sulfonimidoylpurinone substitués dans la position 7 pour le traitement et la prophylaxie d'infection virale | |
MA41134A (fr) | Composés substitués de 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione pour le traitement et la prophylaxie des infections virales | |
MA41338A (fr) | Composés de pyrazine pour le traitement de maladies infectieuses | |
MA39721A (fr) | Nouvelles héteroaryldihydropyrimidines condensées en position 6 pour le traitement et la prophylaxie d'une infection à virus de l'hépatite b | |
MA42410A (fr) | Oxystérols et leurs méthodes d'utilisation | |
MA37942B1 (fr) | Hétéroaryldihydropyrimidines d'acide 6-aminé pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b | |
MA37866B1 (fr) | Dérivés de type aza-indazole ou diaza-indazole pour le traitement de la douleur | |
MA40225A (fr) | Composés dihydroisoquinolinone substitués | |
MA40523A (fr) | 2-(morpholin-4-yl)-1,7-naphthyridines | |
MA37712A2 (fr) | Inhibiteurs macrocycliques de virus flaviviridae | |
MX2018009944A (es) | Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbon il-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a- tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico. | |
TN2016000188A1 (fr) | Derives de purines 2,6-substitues et leur utilisation dans le traitement de troubles proliferatifs. | |
MA38315A1 (fr) | Composés tétracycliques substitués par un hétérocycle et procédés pour les utiliser pour le traitement de maladies virales | |
TN2015000547A1 (fr) | Composes heteroaromatiques et leur utilisation comme ligands de dopamine d1 | |
MA37891B1 (fr) | Alcoxypyrazoles comme activateurs de guanylate cyclase soluble | |
MA35601B1 (fr) | Pyrrolotriazines substituées par hydroxyméthylaryle utilisées comme inhibiteurs d'alk1 | |
PH12017502009A1 (en) | Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection | |
MA54653B1 (fr) | Modulateurs du récepteur de cxcr7 pipéridine | |
MA38009A1 (fr) | Composes d'azaindoline substitues qui ont une activite inhibitrice de la proteine d'apoptose pour leurs utilisations dans le traitement et/ou la prophylaxie du cancer | |
MA42972B1 (fr) | Nouveaux composés sulfonimidoylpurinone et dérivés pour le traitement et la prophylaxie d'infection virale | |
MA38591A1 (fr) | Héteroaryldihydropyrimidines pontées en position 6 pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b | |
FR3028762B1 (fr) | Derives hydroxybisphosphoniques hydrosolubles de la doxorubicine | |
MA38878A1 (fr) | Nouveaux composés (s)-3-chloro-3-fluoro-tetrahydro-furane inhibiteurs de la polymérase du virus de l'hépatite c, utiles pour le traitement ou la prophylaxie de l'infection par le virus de l'hepatite c | |
MA49910B1 (fr) | Activateurs de la pyruvate kinase destinés à être utilisés dans le traitement de troubles sanguins | |
MA42411B1 (fr) | Oxystérols et leurs procédés d'utilisation |